Nuveen
IBIO icon

Nuveen’s iBio IBIO Stock Holding History

Nuveen’s Portfolio IBIO Stock Details IBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,796
Closed -$360K – 3362
2022
Q1 		$360K Sell
1,796
-17
-0.9% -$3.56K ﹤0.01% 3086
2021
Q4 		$580K Sell
1,813
-143
-7% -$54.5K ﹤0.01% 3037
2021
Q3 		$1.2M Buy
1,956
+19
+1% +$11.8K ﹤0.01% 2920
2021
Q2 		$1.46M Buy
1,937
+716
+59% +$522K ﹤0.01% 2850
2021
Q1 		$940K Buy
1,221
+135
+12% +$118K ﹤0.01% 2904
2020
Q4 		$570K Buy
1,086
+514
+90% +$419K ﹤0.01% 3012
2020
Q3 		$581K Buy
572
+11
+2% +$15.9K ﹤0.01% 2901
2020
Q2 		$623K Buy
+561
New +$367K ﹤0.01% 2817

Other funds holding IBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
E
Ergoteles New York $68.2M AUM 36.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Nuveen's IBIO Position: Q2 2022 in Review

Nuveen sold out of iBio (IBIO) in Q2 2022, closing a stake of 1,796 shares — an estimated $360K sold.

Nuveen first reported a position in IBIO in Q2 2020 and held it in 8 quarters. The position peaked at $1.46M in Q2 2021. 53 funds tracked by Wall St. Rank hold IBIO as of Q2 2022.

  • Nuveen reported no remaining iBio position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 1,796 iBio shares in Q2 2022, an estimated $360K.
  • Nuveen first reported a position in iBio in Q2 2020 and held it in 8 quarters.
  • Nuveen's iBio position peaked at $1.46M in Q2 2021.
  • 53 funds tracked by Wall St. Rank held iBio as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.